Riverside

AstraZeneca to seek US approval of COVID vaccine – Riverside, California

Riverside, California 2021-07-29 04:22:19 –

The United Kingdom, the European Union, and the World Health Organization have already approved the use of the AstraZeneca vaccine.

London, UK — AstraZeneca announced Thursday that it plans to seek US approval for the COVID-19 vaccine later this year and will present a new schedule for a significantly delayed application.

The Swedish pharmaceutical company announced its schedule when it announced its financial results for the second quarter. This shows that the company and its sublicenses provided more than 700 million vaccines to more than 170 countries in the first half of this year. This includes the 80 million doses used in the COVAX initiative for low- and middle-income countries.

Due to the time frame shift, news about filing in the United States is being watched carefully.

When AstraZeneca released data on vaccine trials in the United States on March 22, company officials said they would seek approval from the Food and Drug Administration in early April. The company said in April that it plans to file a US application “in the coming weeks.”

The United Kingdom, the European Union, and the World Health Organization have already approved the use of the AstraZeneca vaccine.

Related: Report: Pfizer, Modana Expands COVID Vaccine Research for Children 5-11 Years

Related: Incorrect information for fact checking after CDC updates COVID-19 mask guidance

AstraZeneca reported revenue of $ 1.17 billion in the first half of the year from 319 million doses of vaccine delivered directly from the company. AstraZeneca has promised to provide the vaccine on a non-profit basis for as long as the pandemic continues.

Despite complaints about vaccine supply from the EU, Block in 27 countries received more doses directly from AstraZeneca than any other unitary entity earlier this year. The company has shipped 97 million shipments to the EU, 65 million shipments to Brazil and 52 million shipments to the United Kingdom.

According to AstraZeneca, Gabi, an alliance to secure vaccines for low-income countries, received 49 million doses, with an additional 57 million doses to other countries.

Sublicensees, including the Serum Institute of India, have delivered millions of doses and boosted global doses to more than 700 million.

This vaccine was developed by researchers at Oxford University. Researchers at Oxford University have licensed this technology to AstraZeneca to take advantage of AstraZeneca’s global manufacturing and distribution capabilities. Next, AstraZeneca approves other companies to make shots around the world.

AstraZeneca to seek US approval of COVID vaccine Source link AstraZeneca to seek US approval of COVID vaccine

Back to top button